iPSC Therapy for Spinal Cord Injury in China | Access & Costs Explore FDA-cleared iPSC stem cell therapy for spinal cord injury in China. Learn about clinical trial data, comprehensive costs, and secure medical access for international patients.

Exploring advanced SCI treatments?

FDA-cleared iPSC stem cell therapy for Spinal Cord Injury is now accessible via Medical Tourism China.

Read our complete guide: zurl.co/iJ1xf

#SpinalCordInjury #iPSCTherapy #MedicalConcierge #MedBridgeNZ #ChinaMedicalTourism

A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy Shimmura and colleagues demonstrate the feasibility of using iPSC-derived cells for treating bullous keratopathy. Although adverse reactions are not observed, de novo gene mutations can be detected de...

First in human study of CLS001, an iPSC-derived corneal cell, shows 100% safety & 20/40 vision! #iPSCtherapy PMID:39809262, Cell Rep Med 2025 www.cell.com/cell-reports...